Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 19/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2717953 | 0.88 | GAA (1.00) | GAAKMT2AMEN1SMN1; SMN2POLB | |
| SCHEMBL2716754 | 0.85 | GAA (1.00) | GAAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL2717423 | 0.85 | GAA (1.00) | GAAKMT2AMEN1SMN1; SMN2TDP1 | |
| SCHEMBL2717892 | 0.85 | GAA (1.00) | GAAKMT2AMEN1SMN1; SMN2POLB | |
| SCHEMBL2718876 | 0.84 | GAA (1.00) | GAAKMT2APOLBRXFP1TDP1 | |
| SCHEMBL29477262 | 0.84 | GAA (1.00) | GAAKMT2APOLBRXFP1TDP1 | |
| SCHEMBL10080666 | 0.83 | GAA (1.00) | GAAKMT2AMEN1SMN1; SMN2TDP1 | |
| SCHEMBL2718073 | 0.83 | GAA (1.00) | GAAKMT2AMEN1SMN1; SMN2TDP1 | |
| SCHEMBL10080665 | 0.83 | GAA (1.00) | GAAKMT2AMEN1SMN1; SMN2TDP1 | |
| SCHEMBL2718327 | 0.83 | GAA (1.00) | GAAKMT2AMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012061597-A1 | ALPHA-GLUCOSIDASE BINDERS AND METHODS OF THEIR USE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH (US) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012061597-A1 | ALPHA-GLUCOSIDASE BINDERS AND METHODS OF THEIR USE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH (US) | 2012-05-10 | — | — | WO | disclosed |